UNLOCKING THE POWER OF BIOSENSORS.
AQ Biotech’s phage-biosensors represent cutting-edge technology for rapid, accurate, and affordable disease detection and monitoring. By leveraging the power of engineered phages and non-invasive biological sampling, the company seeks to renew the global healthcare diagnostics market and unlock the potential of personalized treatment response measurement.
Advantages of phage-biosensors in disease detection
Non-invasive.
Unlike most screening and diagnostic tests, AQ Biotech’s biosensor method is non-invasive. It utilizes easily obtainable biological samples, such as saliva and urine, for analysis. Other sample types like sputum and serum can also be used when necessary.
Multi-omics.
Biological samples, their metabolic changes and new biomarkers therein offers complementary data for multi-omics diagnostics and AI, It will significantly improve accuracy over current gold standard tests enabling large-scale screening for severe diseases.
High Specificity.
Accurate and reliable results are crucial for efficient screening and diagnostics.
Our biosensors excel in sensitivity and specificity compared to industry standards.
Cost-Efficient.
To make large-scale screening possible, the test and process must be scalable and affordable. Biosensor-based screening tests offer a unique cost structure that enables population level screening at an unprecedented scale and cost.
